Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities-Reference-Cited by-同舟云学术

Pt(iv) antitumor prodrugs: dogmas, paradigms, and realities

Published:2022 Issue:6 Volume:51 Page:2121-2134
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Ravera Mauro¹^ORCID,Gabano Elisabetta¹^ORCID,McGlinchey Michael J.²,Osella Domenico¹^ORCID

Affiliation:

1. Dipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale, Viale Michel 11, Alessandria, Italy

2. UCD School of Chemistry, University College Dublin, Belfield, Dublin 4, Ireland

Abstract

Pt(IV) complexes are promising antitumor prodrugs releasing active Pt(II) moieties. Multi-functional Pt(IV) complexes contain two or more synergistic moieties. Many Pt(IV) prodrugs show encouraging pharmacological profiles.

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D1DT03886A

Reference162 articles.

1. Immunotherapy and targeted therapy—the new roadmap in cancer treatment

2. Principles of systemic anticancer therapy

3. The resurgence of platinum-based cancer chemotherapy

4. The rediscovery of platinum-based cancer therapy

5. Unexpected therapeutic effects of cisplatin

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer;Cancers;2024-07-15

2. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead;ChemMedChem;2024-07-05

3. Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs;Journal of Medicinal Chemistry;2024-05-31

4. Platinum-based drugs in cancer treatment: Expanding horizons and overcoming resistance;Journal of Molecular Structure;2024-04

5. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity;International Journal of Molecular Sciences;2024-02-11